Romania · Delayed Price · Currency is RON Biofarm Statistics
Total Valuation
Biofarm has a market cap or net worth of RON 1.35 billion. The enterprise value is 1.14 billion.
| Market Cap | 1.35B |
| Enterprise Value | 1.14B |
Important Dates
The last earnings date was Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Jun 29, 2026 |
Share Statistics
Biofarm has 985.37 million shares outstanding. The number of shares has increased by 0.75% in one year.
| Current Share Class | 985.37M |
| Shares Outstanding | 985.37M |
| Shares Change (YoY) | +0.75% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 88.43% |
| Float | 476.14M |
Valuation Ratios
The trailing PE ratio is 19.13.
| PE Ratio | 19.13 |
| Forward PE | n/a |
| PS Ratio | 4.59 |
| PB Ratio | 3.42 |
| P/TBV Ratio | 3.44 |
| P/FCF Ratio | 25.47 |
| P/OCF Ratio | 19.00 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.77, with an EV/FCF ratio of 21.57.
| EV / Earnings | 14.61 |
| EV / Sales | 3.88 |
| EV / EBITDA | 12.77 |
| EV / EBIT | 16.75 |
| EV / FCF | 21.57 |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.00.
| Current Ratio | 1.90 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 17.55% and return on invested capital (ROIC) is 22.35%.
| Return on Equity (ROE) | 17.55% |
| Return on Assets (ROA) | 7.14% |
| Return on Invested Capital (ROIC) | 22.35% |
| Return on Capital Employed (ROCE) | 17.20% |
| Weighted Average Cost of Capital (WACC) | 7.02% |
| Revenue Per Employee | 786,775 |
| Profits Per Employee | 209,231 |
| Employee Count | 374 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 0.67 |
Taxes
In the past 12 months, Biofarm has paid 10.43 million in taxes.
| Income Tax | 10.43M |
| Effective Tax Rate | 11.76% |
Stock Price Statistics
The stock price has increased by +64.27% in the last 52 weeks. The beta is 0.51, so Biofarm's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +64.27% |
| 50-Day Moving Average | 1.37 |
| 200-Day Moving Average | 1.19 |
| Relative Strength Index (RSI) | 58.82 |
| Average Volume (20 Days) | 62,554 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biofarm had revenue of RON 294.25 million and earned 78.25 million in profits. Earnings per share was 0.07.
| Revenue | 294.25M |
| Gross Profit | 252.39M |
| Operating Income | 68.25M |
| Pretax Income | 88.68M |
| Net Income | 78.25M |
| EBITDA | 89.50M |
| EBIT | 68.25M |
| Earnings Per Share (EPS) | 0.07 |
Balance Sheet
The company has 208.02 million in cash and 1.13 million in debt, with a net cash position of 206.88 million or 0.21 per share.
| Cash & Cash Equivalents | 208.02M |
| Total Debt | 1.13M |
| Net Cash | 206.88M |
| Net Cash Per Share | 0.21 |
| Equity (Book Value) | 395.18M |
| Book Value Per Share | 0.40 |
| Working Capital | 187.83M |
Cash Flow
In the last 12 months, operating cash flow was 71.03 million and capital expenditures -18.04 million, giving a free cash flow of 52.99 million.
| Operating Cash Flow | 71.03M |
| Capital Expenditures | -18.04M |
| Depreciation & Amortization | 21.26M |
| Net Borrowing | n/a |
| Free Cash Flow | 52.99M |
| FCF Per Share | 0.05 |
Margins
Gross margin is 85.77%, with operating and profit margins of 23.19% and 26.59%.
| Gross Margin | 85.77% |
| Operating Margin | 23.19% |
| Pretax Margin | 30.14% |
| Profit Margin | 26.59% |
| EBITDA Margin | 30.42% |
| EBIT Margin | 23.19% |
| FCF Margin | 18.01% |
Dividends & Yields
This stock pays an annual dividend of 0.18, which amounts to a dividend yield of 13.30%.
| Dividend Per Share | 0.18 |
| Dividend Yield | 13.30% |
| Dividend Growth (YoY) | 487.94% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 254.49% |
| Buyback Yield | -0.75% |
| Shareholder Yield | 2.41% |
| Earnings Yield | 5.80% |
| FCF Yield | 3.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 30, 2008. It was a forward split with a ratio of 1.12001.
| Last Split Date | Apr 30, 2008 |
| Split Type | Forward |
| Split Ratio | 1.12001 |
Scores
Biofarm has an Altman Z-Score of 4.82 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.82 |
| Piotroski F-Score | 4 |